#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain stem glioma Oesophageal squamous cell carcinoma stage III Cryoglobulinaemia Thrombocytopenia Primary adrenal insufficiency Familial dilated cardiomyopathy Becker's muscular dystrophy Acute graft versus host disease in intestine Superficial vein thrombosis Thymic carcinoma Osteosarcoma Hepatic angiosarcoma Fibrodysplasia ossificans progressiva Choroid melanoma Chronic granulomatous disease More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Diagnostics Friedreich’s ataxia – Life with Disease Fragile X syndrome – Basic Information Biotinidase deficiency Castleman’s disease – Basic Information Mantle cell lymphoma stage IV – Treatment Leiomyosarcoma – Trials in Disease Primary mediastinal large B-cell lymphoma – Life with Disease Chondrosarcoma metastatic – Treatment Lymphangiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Sulfate Heptahydrate Orismilast Dexamfetamine Sulfate Fosamprenavir Calcium Phenylalanine Platelet Concentrate Everolimus Bleomycin Sulfate Ph. Eur. Goserelin Dextran 70 ULEFNERSEN Anhydrous Cidofovir Bepirovirsen Tozinameran 1,3-BUTYLENE GLYCOL Balcinrenone Emibetuzumab Desloratadine Paxalisib AVTX-009 More therapies…

    Learn about Your Condition

    Shock Lymphocyte adoptive therapy Lupus nephritis Gouty arthritis Endocarditis Vascular dementia Stress urinary incontinence HER2 negative breast cancer Allergic respiratory disease Acute cardiac event Oxygen therapy Guttate psoriasis Rectal cancer recurrent Mumps Cutaneous calcification More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

    Recruiting

    3 1 1
    Investigated Drugs:
    • Atogepant
    Belgium Denmark France Hungary Italy The Netherlands +5

  • Study on the Effects of Nefopam and Sodium Chloride for Pain Relief After Total Hip Replacement Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hip arthroplasty
    Investigated Drugs:
    • Nefopam
    • Sodium Chloride
    France

  • Study on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dilated cardiomyopathy
    Investigated Drugs:
    • Candesartan Cilexetil
    The Netherlands Spain

  • Study on Glyceryl Trinitrate for Treating Esophageal Food Impaction in Adults

    Recruiting

    2 1 1
    Investigated Diseases:
    • Oesophageal food impaction
    Investigated Drugs:
    • Glyceryl Trinitrate
    Denmark

  • Study on the Safety of GRWD5769 Alone and with Cemiplimab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Grwd5769
    • Cemiplimab
    France Spain

  • Study of Glofitamab with Rituximab or Obinutuzumab and Drug Combination for Untreated Richter’s Syndrome Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Glofitamab
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    France
Previous Page
1 … 603 604 605 606 607 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!